Literature DB >> 19816198

Mitochondrial ferritin in the substantia nigra in restless legs syndrome.

Amanda M Snyder1, XinSheng Wang, Stephanie M Patton, Paolo Arosio, Sonia Levi, Christopher J Earley, Richard P Allen, James R Connor.   

Abstract

Restless legs syndrome (RLS) is a neurological disorder that is thought to involve decreased iron availability in the brain. Iron is required for oxidative metabolism and plays a critical role in redox reactions in mitochondria. The recent discovery of mitochondrial ferritin (FtMt) provided the opportunity to identify a potential correlation between iron and mitochondrial function in RLS. Human substantia nigra (SN) and putamen autopsy samples from 8 RLS cases and 8 controls were analyzed. Mitochondrial ferritin levels in RLS SN tissue homogenate samples assessed by immunoblots had more FtMt than control samples (p < 0.01), whereas there were no significant differences in FtMt in the putamen samples. By immunohistochemistry, neuromelanin-containing neurons in the SN were the predominant cell type expressing FtMt. Staining in neurons in RLS samples was consistently greater than that in controls. Cytochrome c oxidase staining, which reflects numbers of mitochondria, showed a similar staining pattern to that of FtMt, whereas there was less immunostaining in the RLS cases for cytosolic H-ferritin. These results suggest that increased numbers of mitochondria in neurons in RLS and increased FtMt might contribute to insufficient cytosolic iron levels in RLS SN neurons; they are consistent with the hypothesis that energy insufficiency in these neurons may be involved in the pathogenesis of RLS.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19816198      PMCID: PMC3024883          DOI: 10.1097/NEN.0b013e3181bdc44f

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  43 in total

1.  A human mitochondrial ferritin encoded by an intronless gene.

Authors:  S Levi; B Corsi; M Bosisio; R Invernizzi; A Volz; D Sanford; P Arosio; J Drysdale
Journal:  J Biol Chem       Date:  2001-04-25       Impact factor: 5.157

Review 2.  Insight into the pathophysiology of restless legs syndrome.

Authors:  C J Earley; R P Allen; J L Beard; J R Connor
Journal:  J Neurosci Res       Date:  2000-12-01       Impact factor: 4.164

3.  MRI measurement of brain iron in patients with restless legs syndrome.

Authors:  R P Allen; P B Barker; F W Wehrl; F Wehrl; H K Song; C J Earley
Journal:  Neurology       Date:  2001-01-23       Impact factor: 9.910

4.  Regulation of the 75-kDa subunit of mitochondrial complex I by iron.

Authors:  E Lin; J H Graziano; G A Freyer
Journal:  J Biol Chem       Date:  2001-04-19       Impact factor: 5.157

5.  Autofluorescence of melanins induced by ultraviolet radiation and near ultraviolet light. A histochemical and biochemical study.

Authors:  M Elleder; J Borovanský
Journal:  Histochem J       Date:  2001-05

Review 6.  Iron regulatory proteins and the molecular control of mammalian iron metabolism.

Authors:  R S Eisenstein
Journal:  Annu Rev Nutr       Date:  2000       Impact factor: 11.848

7.  Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome.

Authors:  J R Connor; P J Boyer; S L Menzies; B Dellinger; R P Allen; W G Ondo; C J Earley
Journal:  Neurology       Date:  2003-08-12       Impact factor: 9.910

8.  Age-related irreversible progressive nigrostriatal dopaminergic neurotoxicity in the paraquat and maneb model of the Parkinson's disease phenotype.

Authors:  Mona Thiruchelvam; Alison McCormack; Eric K Richfield; Raymond B Baggs; A William Tank; Donato A Di Monte; Deborah A Cory-Slechta
Journal:  Eur J Neurosci       Date:  2003-08       Impact factor: 3.386

Review 9.  Mitochondrial ferritin: a new player in iron metabolism.

Authors:  Jim Drysdale; Paolo Arosio; Rosangela Invernizzi; Mario Cazzola; Armin Volz; Barbara Corsi; Giorgio Biasiotto; Sonia Levi
Journal:  Blood Cells Mol Dis       Date:  2002 Nov-Dec       Impact factor: 3.039

10.  Human mitochondrial ferritin expressed in HeLa cells incorporates iron and affects cellular iron metabolism.

Authors:  Barbara Corsi; Anna Cozzi; Paolo Arosio; Jim Drysdale; Paolo Santambrogio; Alessandro Campanella; Giorgio Biasiotto; Alberto Albertini; Sonia Levi
Journal:  J Biol Chem       Date:  2002-04-12       Impact factor: 5.157

View more
  26 in total

1.  Restless legs and substantia nigra hypoechogenicity are common features in Friedreich's ataxia.

Authors:  Matthis Synofzik; Jana Godau; Tobias Lindig; Ludger Schöls; Daniela Berg
Journal:  Cerebellum       Date:  2011-03       Impact factor: 3.847

2.  Restless legs syndrome: pathophysiology and treatment.

Authors:  William G Ondo
Journal:  Curr Treat Options Neurol       Date:  2014-11       Impact factor: 3.598

3.  Over-expression of mitochondrial ferritin affects the JAK2/STAT5 pathway in K562 cells and causes mitochondrial iron accumulation.

Authors:  Paolo Santambrogio; Benedetta Gaia Erba; Alessandro Campanella; Anna Cozzi; Vincenza Causarano; Laura Cremonesi; Anna Gallì; Matteo Giovanni Della Porta; Rosangela Invernizzi; Sonia Levi
Journal:  Haematologica       Date:  2011-06-28       Impact factor: 9.941

4.  Endothelial cells are critical regulators of iron transport in a model of the human blood-brain barrier.

Authors:  Brian Chiou; Emma H Neal; Aaron B Bowman; Ethan S Lippmann; Ian A Simpson; James R Connor
Journal:  J Cereb Blood Flow Metab       Date:  2018-06-18       Impact factor: 6.200

Review 5.  Ferritins in Kidney Disease.

Authors:  Kayla McCullough; Subhashini Bolisetty
Journal:  Semin Nephrol       Date:  2020-03       Impact factor: 5.299

Review 6.  [Iron deficiency, Fatigue and Restless-Legs-Syndrome].

Authors:  Bettina Wurzinger; Peter König
Journal:  Wien Med Wochenschr       Date:  2016-08-30

7.  Iron-deficiency and dopaminergic treatment effects on RLS-Like behaviors of an animal model with the brain iron deficiency pattern of the restless legs syndrome.

Authors:  Richard P Allen; Christopher J Earley; Byron C Jones; Erica L Unger
Journal:  Sleep Med       Date:  2020-02-05       Impact factor: 3.492

8.  Ropinirole in restless legs syndrome and periodic limb movement disorder.

Authors:  Daniel Erichsen; Raffaelle Ferri; David Gozal
Journal:  Ther Clin Risk Manag       Date:  2010-04-15       Impact factor: 2.423

Review 9.  Restless Leg Syndrome/Willis-Ekbom Disease Pathophysiology.

Authors:  Richard P Allen
Journal:  Sleep Med Clin       Date:  2015-07-15

Review 10.  Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities.

Authors:  Neena Singh; Swati Haldar; Ajai K Tripathi; Katharine Horback; Joseph Wong; Deepak Sharma; Amber Beserra; Srinivas Suda; Charumathi Anbalagan; Som Dev; Chinmay K Mukhopadhyay; Ajay Singh
Journal:  Antioxid Redox Signal       Date:  2013-08-15       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.